182 related articles for article (PubMed ID: 19539615)
1. Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.
Labbozzetta M; Baruchello R; Marchetti P; Gueli MC; Poma P; Notarbartolo M; Simoni D; D'Alessandro N
Chem Biol Interact; 2009 Sep; 181(1):29-36. PubMed ID: 19539615
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.
Simoni D; Rizzi M; Rondanin R; Baruchello R; Marchetti P; Invidiata FP; Labbozzetta M; Poma P; Carina V; Notarbartolo M; Alaimo A; D'Alessandro N
Bioorg Med Chem Lett; 2008 Jan; 18(2):845-9. PubMed ID: 18039573
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Wanming D; Zhang D; Liu Q; Kang J
Pharmazie; 2005 Jan; 60(1):57-61. PubMed ID: 15700780
[TBL] [Abstract][Full Text] [Related]
4. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
5. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.
Lin L; Shi Q; Su CY; Shih CC; Lee KH
Bioorg Med Chem; 2006 Apr; 14(8):2527-34. PubMed ID: 16427289
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Bai H; Wang C; Kang J
Pharmazie; 2006 Aug; 61(8):710-6. PubMed ID: 16964716
[TBL] [Abstract][Full Text] [Related]
7. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
[TBL] [Abstract][Full Text] [Related]
8. Anti- and pro-oxidant effects of oxidized quercetin, curcumin or curcumin-related compounds with thiols or ascorbate as measured by the induction period method.
Fujisawa S; Kadoma Y
In Vivo; 2006; 20(1):39-44. PubMed ID: 16433026
[TBL] [Abstract][Full Text] [Related]
9. Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin.
Chakraborti S; Dhar G; Dwivedi V; Das A; Poddar A; Chakraborti G; Basu G; Chakrabarti P; Surolia A; Bhattacharyya B
Biochemistry; 2013 Oct; 52(42):7449-60. PubMed ID: 24063255
[TBL] [Abstract][Full Text] [Related]
10. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies of curcumin analogues.
Fuchs JR; Pandit B; Bhasin D; Etter JP; Regan N; Abdelhamid D; Li C; Lin J; Li PK
Bioorg Med Chem Lett; 2009 Apr; 19(7):2065-9. PubMed ID: 19249204
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1-benzyl-3-(5-hydroxymethyl-2-furyl)selenolo[3,2-c]pyrazole derivatives as new anticancer agents.
Chou LC; Huang LJ; Hsu MH; Fang MC; Yang JS; Zhuang SH; Lin HY; Lee FY; Teng CM; Kuo SC
Eur J Med Chem; 2010 Apr; 45(4):1395-402. PubMed ID: 20097456
[TBL] [Abstract][Full Text] [Related]
13. Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C.
Das J; Pany S; Panchal S; Majhi A; Rahman GM
Bioorg Med Chem; 2011 Nov; 19(21):6196-202. PubMed ID: 21975067
[TBL] [Abstract][Full Text] [Related]
14. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.
Liang G; Shao L; Wang Y; Zhao C; Chu Y; Xiao J; Zhao Y; Li X; Yang S
Bioorg Med Chem; 2009 Mar; 17(6):2623-31. PubMed ID: 19243951
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.
Adams BK; Ferstl EM; Davis MC; Herold M; Kurtkaya S; Camalier RF; Hollingshead MG; Kaur G; Sausville EA; Rickles FR; Snyder JP; Liotta DC; Shoji M
Bioorg Med Chem; 2004 Jul; 12(14):3871-83. PubMed ID: 15210154
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
Ganta S; Amiji M
Mol Pharm; 2009; 6(3):928-39. PubMed ID: 19278222
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety.
Ratković Z; Juranić ZD; Stanojković T; Manojlović D; Vukićević RD; Radulović N; Joksović MD
Bioorg Chem; 2010 Feb; 38(1):26-32. PubMed ID: 19846191
[TBL] [Abstract][Full Text] [Related]
19. Design and development of water-soluble curcumin conjugates as potential anticancer agents.
Safavy A; Raisch KP; Mantena S; Sanford LL; Sham SW; Krishna NR; Bonner JA
J Med Chem; 2007 Nov; 50(24):6284-8. PubMed ID: 17973470
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?
Narlawar R; Pickhardt M; Leuchtenberger S; Baumann K; Krause S; Dyrks T; Weggen S; Mandelkow E; Schmidt B
ChemMedChem; 2008 Jan; 3(1):165-72. PubMed ID: 17943713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
